Hybrids of 1,4-Naphthoquinone with Thymidine Derivatives: Synthesis, Anticancer Activity, and Molecular Docking Study
Molecules · 2023
DOI: 10.3390/molecules28186644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Monika Kadela-Tomanek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, 4 Jagiellońska Str., 41-20…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Head and Neck Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia in Katowice, Poland.
Abstract (Originalsprache)
One of the most essential health problems is cancer, the first or second cause of death worldwide. Head and neck cancers are hard to detect due to non-specific symptoms. The treatment often relies on a combination of radio and chemotherapy. For this reason, the research of new anticancer compounds is fundamental. The natural and synthetic compounds with 1,4-naphthoquinone scaffold is characterized by high anticancer activity. The study aimed to evaluate the synthesis and anticancer activity of hybrids 1,4-naphthoquinone with thymidine derivatives. The series of compounds allows us to check the influence of the substituent in the C3′ position of the thymidine moiety on the cytotoxicity against squamous cancer cell lines (SCC-9 and SCC-25) and submandibular gland cancer (A-253). An annexin V/propidium iodide (PI) co-staining assay shows that derivatives cause the apoptotic in SCC-25 and A-253 cell lines. The molecular docking study examined the interaction between the active site of the BCL-2 protein and the hybrids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.
- Silesia LabMed, Centre for Research and Implementation, Medical University of Silesia in Katowice, 18 Medyków Str., 40-752 Katowice, Poland.
- Department of Pathology, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Ostrogórska 30, 41-200 Sosnowiec, Poland.
ORCID-Profile: Monika Kadela-Tomanek, Kamil Krzykawski, Robert Kubina
Förderung
- Medical University of Silesia in Katowice, Poland
Zitieren
APA
Kadela-Tomanek, M., Krzykawski, K., Halama, A., & Kubina, R. (2023). Hybrids of 1,4-Naphthoquinone with Thymidine Derivatives: Synthesis, Anticancer Activity, and Molecular Docking Study. Molecules. https://doi.org/10.3390/molecules28186644
Vancouver
Kadela-Tomanek M, Krzykawski K, Halama A, Kubina R. Hybrids of 1,4-Naphthoquinone with Thymidine Derivatives: Synthesis, Anticancer Activity, and Molecular Docking Study. Molecules. 2023. doi:10.3390/molecules28186644
BibTeX
@article{KadelaTomanek2023,
author = {Kadela-Tomanek, Monika and Krzykawski, Kamil and Halama, Adrianna and Kubina, Robert},
title = {Hybrids of 1,4-Naphthoquinone with Thymidine Derivatives: Synthesis, Anticancer Activity, and Molecular Docking Study},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28186644}
}
EUVIMED